DSR Corp (155660) — Free Cash Flow Generation Index

Latest as of March 2026: 0.59x

DSR Corp (155660) has a Free Cash Flow Generation Index of 0.59x as of March 2026. Free cash flow of ₩5.67 Billion represents 1% of operating cash flow (₩9.68 Billion). Explore 155660 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.59x
Free Cash Flow / Operating CF

Free Cash Flow

₩5.67 Billion
KRW

Operating Cash Flow

₩9.68 Billion
KRW

Capital Expenditures

₩4.01 Billion
KRW

DSR Corp Free Cash Flow Generation Index (2013–2025)

Historical FCF Generation Index trend for DSR Corp across 13 annual periods. For the full cash flow conversion analysis, see 155660 cash generation efficiency.

Annual Free Cash Flow Generation for DSR Corp (2013–2025)

Year-by-year Free Cash Flow Generation Index for DSR Corp. Check how aggressively does DSR Corp reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2025 0.11x ₩2.14 Billion ₩19.76 Billion ₩17.63 Billion ▲ +131.5%
2024 -0.34x ₩-5.79 Billion ₩16.84 Billion ₩22.63 Billion ▼ -143.5%
2023 0.79x ₩17.81 Billion ₩22.52 Billion ₩4.71 Billion ▲ +271.6%
2022 -0.46x ₩-24.02 Billion ₩52.11 Billion ₩76.13 Billion ▲ +14.6%
2021 -0.54x ₩-2.88 Billion ₩5.33 Billion ₩8.21 Billion ▼ -210.0%
2020 0.49x ₩8.51 Billion ₩17.35 Billion ₩8.84 Billion ▲ +28.0%
2019 0.38x ₩5.27 Billion ₩13.76 Billion ₩8.49 Billion ▲ +126.5%
2018 -1.45x ₩-6.63 Billion ₩4.58 Billion ₩11.21 Billion ▲ +63.1%
2017 -3.92x ₩-25.14 Billion ₩6.41 Billion ₩31.55 Billion ▼ -343.9%
2016 1.61x ₩16.92 Billion ₩10.53 Billion ₩6.40 Billion ▲ +29.6%
2015 1.24x ₩35.01 Billion ₩28.24 Billion ₩6.78 Billion ▼ -65.3%
2014 3.57x ₩10.08 Billion ₩2.82 Billion ₩7.26 Billion ▲ +24.7%
2013 2.87x ₩11.95 Billion ₩4.17 Billion ₩7.78 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).